Scientists have reportedly developed a new drug with the potential to prevent the breakdown of nerves and brain cells that may result in Parkinson’s, Alzheimer’s, and motor neuron diseases. As per trusted sources, the drug has been developed from supercharged vitamin A, a micronutrient that’s …
International Business Machines Corporation (IBM), a leading American multinational IT (Information Technology) company, has made it to the headlines for developing an innovative ‘Fingernail Sensor’ prototype. Apparently, the sensor employs AI (Artificial Intelligence) and Machine Learning for monitoring and analyzing human health and disease progression. …
The $27 million were raised in a Series-C financing with investors like Bristol-Myers Squibb and Bill & Melinda Gates Foundation participating in the round. The money would be utilized to advance the company’s microbiome-derived product candidates. Vedanta Biosciences, Inc. (Vedanta), a renowned PureTech Health affiliate, …
Relay Therapeutics, a privately-held biotechnology company based in Cambridge, Massachusetts, is currently in the news for securing $400 million in venture capital financing during a Series C funding round. The Series C funding, led by SoftBank Vision Fund, was participated in by new investors including …
Voluntis, a company specializing in digital therapeutics, has reportedly announced that it has formed a collaboration with research-based global biopharmaceutical company AbbVie, in order to improve patient care coordination in immunology through innovative digital therapeutic software. As per trusted sources, the companies will collectively leverage …
The U.S.-based global pharmaceutical firm Eli Lilly & Company, and California-based immunotherapy company, Aduro Biotech, are currently in the news for announcing a research collaboration, as well as an exclusive license deal, for the cGAS-STING pathway inhibitor program that would develop new immunotherapies for inflammatory …
Biotech firm Kineta has recently announced an agreement with pharmaceutical corporation Pfizer, which includes an upfront payment of $15 million and possibly an additional $505 million down the line. With this deal, Seattle-based Kineta, Inc. has certainly received a boost towards its efforts of killing …
Roche Holding AG has reportedly been granted the PRIME (PRIority MEdicines) designation in Europe for its risdiplam, a small-molecule drug for spinal muscular atrophy which could be a rival to Spinraza from Biogen Inc. As of now, risdiplam is allegedly in three studies which include …
The South East Regional Health Authority (SERHA), a statutory body of the Ministry of Health, Jamaica, has been reportedly handed over a mobile human immunodeficiency virus (HIV) testing unit that is valued at over $12 million. Apparently, the testing unit was donated by the United …
